Header Logo

Connection

STACEY BERG to Hodgkin Disease

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about Hodgkin Disease.
STACEY BERG
Connection Strength
0.141
Hodgkin Disease
  1. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 04; 21(4):541-550.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.